LVEF decreases were reported in 2.5% of patients who received lapatinib in combination with capecitabine, as compared to 1.0% with capecitabine alone.
LVEF: n pienenemistä raportoitiin 2, 5 prosentilla potilaista, jotka saivat lapatinibia yhdessä kapesitabiinin kanssa, ja 1, 0 prosentilla pelkkää kapesitabiinia saaneista potilaista.